Tuesday, November 14, 2017 10:32:06 AM
Really seems like only a matter of time until Novartis acquires Conatus. But is that a bitter pill to swallow since it was part of Novartis to begin with? Or is that just a BP strategy to look like they are geniuses? "Spin-off" something they know is going to succeed--let them fund themselves up to a certain stage so that "drain" isn't on your financials--but keep a monetary leash on it so you don't lose it to a competitor, then "acquire" it and look like you're making the smartest acquisitions for your investors. Anyone know of any precedent like that?
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM